腹腔镜手术治疗贲门失弛缓症5例报道

目的探讨腹腔镜微创手术治疗贲门失弛缓症的应用价值。方法 2007年11月至2009年12月期间,中国医科大学附属盛京医院微创外科对5例贲门失弛缓症患者实施腹腔镜改良Heller手术并胃底折叠术。结果手术过程顺利,手术时间120~165 min,平均139 min;术中失血50~200 ml,平均88 ml;术后第1天进食,吞咽困难症状消失,无手术相关并发症。5例患者均痊愈出院。术后随访8~31个月,平均19个月,无症状复发或出现返流症状。结论腹腔镜手术治疗贲门失弛缓症安全、效果良好,值得进一步推广。     

腹腔镜Heller肌切开联合胃底折叠术在贲门失弛缓症治疗中的应用

目的:探讨腹腔镜Heller肌切开联合胃底折叠术(laparoscopic Heller myotomy with a Toupet fundoplication,LHT)治疗贲门失弛缓症的临床价值。方法:回顾分析2000年4月至2008年4月我院为48例贲门失弛缓症患者行LHT的临床资料。结果:手术均获成功,无中转开腹。手术时间65~150min,平均86min,术中出血5~50ml。术后平均住院5.2d。随访1~24个月,术前吞咽困难症状均缓解。结论:LHT具有定位准确、安全、可靠、创伤小、痛苦轻、疗效好等优点,同时可提高手术质量,减少并发症。LHT治疗贲门失弛缓症值得临床推广。     

腹腔镜Heller手术治疗贲门失弛缓症

目的 探讨腹腔镜Heller手术治疗贲门失弛缓症的疗效及安全性。方法 回顾性分析2008年5月至2011年3月期间行腹腔镜Heller手术的12例贲门失弛缓症病人资料及随访结果。结果 12例病人均完成腹腔镜手术,中位手术时间93（81~109）min,中位术中出血量30（23~48）ml,中位住院天数9（7~10）d。其中2例出现术中食管黏膜破损,经术中修补后均顺利愈合,全部病例围手术期均无出现严重并发症。中位随访时间13（8~21）个月,术后症状缓解成功率91.7%（11/12）。结论 腹腔镜Heller手术治疗贲门失弛缓症疗效可靠并具有较好的安全性。     

胃镜辅助腹腔镜改良Heller手术治疗贲门失弛缓症

目的:探讨胃镜辅助下腹腔镜改良Heller手术治疗贲门失弛缓症的疗效及并发症。方法:为35例贲门失弛缓症患者行胃镜辅助腹腔镜改良Heller术,观察术后症状的解除及并发症情况,随访最少1年,观察术后短期疗效。结果:手术时间60~200 min,出血量10~200 ml。术后住院4~7 d,无一例中转开腹,术后症状均有明显改善。2例患者术中损伤食管黏膜,镜下修补后未出现食管瘘。术后2个月复查钡餐,均未见梗阻,食管扩张较前改善;复查24 h食管pH值基本正常,pH4的时间占(1.4%±2.7%),pH监测的患者中5例(14.3%)提示有病理性酸反流,仅1例患者有轻度症状,保守治疗后症状缓解。术前食管测压显示食管下括约肌压力升高,术后2个月复查压力明显下降。随访1年以上,1例于术后5个月出现食管梗阻,扩张治疗后好转。结论:胃镜辅助腹腔镜改良Heller手术治疗贲门失弛缓症效果明显,并发症少,可在临床上推广应用。     

免气腹辅助3D腹腔镜改良Heller肌切开联合Dor胃底折叠治疗贲门失弛缓症

目的探讨免气腹辅助3D腹腔镜改良Heller肌切开联合Dor胃底折叠治疗贲门失弛缓症的临床价值。方法 2013年7月~2015年11月对32例贲门失弛缓症行免气腹辅助3D腹腔镜下贲门食管肌层切开,联合Dor胃底折叠术(前部180°胃底折叠缝合术)。结果 32例均成功完成免气腹腹腔镜手术,手术时间(71.6±36.8)min,术中出血量(23.6±18.4)ml,住院时间(8.2±2.6)d,无食管漏等并发症及死亡。32例术后随访6~34个月,平均15.3月,Eckardt评分Ⅰ级20例(62.5%),Ⅱ级9例(28.1%),Ⅲ级3例(9.4%);手术有效29例(90.6%),失败3例(9.4%)。23例术后6个月复查食管吞钡造影,食管最大横径(31.1±5.2)mm,较术前(45.3±8.0)mm明显改善(t=11.064,P=0.000)。结论免气腹辅助3D腹腔镜改良Heller联合Dor胃底折叠术治疗贲门失弛缓症疗效满意。     

腹腔镜Heller手术治疗贲门失弛缓症的初步临床经验

目的总结腹腔镜Heller手术治疗贲门失弛缓症的初步临床经验。方法2005年2～8月，对肺功能较差、合并肾功能不全或怀疑存在胸膜腔粘连的8例贲门失弛缓症行腹腔镜下Heller联合Dor胃底折叠手术，并进行随访。结果手术时间70～184min，平均103．8min；1例术中食管穿孔改开腹手术修补成功；术后住院3～10d，平均5．1d。术后随访1～6个月，平均3．8月，7例症状缓解，1例轻度吞咽困难。全组无手术死亡。结论腹腔镜具有刨伤小、术中暴露较佳、术后恢复快、术后住院时间短等优点，腹腔镜下Heller术可作为贲门失弛缓症的首选治疗方法，但是否附加胃底折叠术仍需进一步探讨。     

腹腔镜下Heller肌切开联合Dor胃底折叠术治疗贲门失弛缓症的临床体会(附11例报告)

目的:探讨腹腔镜下Heller肌切开+Dor胃底折叠术治疗贲门失弛缓症的临床疗效及贲门失弛缓症的最新研究进展。方法:回顾分析2015年10月至2017年12月收治的11例贲门失弛缓症患者的临床资料,并追踪随访术后临床短期疗效,比较手术前后患者Eckardt得分、食管扩张直径,术后36 h采用视觉模拟评分法评价疼痛程度。结果:手术均获成功,1例出现食管黏膜破损,延迟出院。手术时间平均(154.2±40.7)min,出血量平均(17.1±9.5)ml,术后36 h疼痛评分平均(2.0±0.5)分,术后平均住院(5.7±2.8)d;术后仍吞咽困难1例,Eckardt评分为4分。手术前后食管扩张直径平均(4.4±1.2)cm与(3.0±0.8)cm,Eckardt评分平均(4.7±0.9)分与(2.2±0.9)分;手术前后差异有统计学意义(P0.05)。结论:腹腔镜下Heller肌切开联合Dor胃底折叠术治疗贲门失弛缓症疗效满意,是理想的治疗方案之一。     

腹腔镜手术治疗胃食管反流病和贲门失弛缓症

目的:探索三种腹腔镜胃底折叠术治疗胃食管反流病及Heller肌切开术治疗贲门失弛缓症的安全性与可行性。方法:1995年12月至2004年9月,经腹腔镜手术治疗了胃食管反流病人45例和贲门失弛缓病人5例。术前常规行胃镜与上消化道钡餐检查者50例,加行食管测酸、测压检查者39例。腹腔镜单纯胃底折叠术10例(Nissen式1例,Toupet式9例);腹腔镜食管裂孔疝修补加胃底折叠术35例(Nissen式11例,Toupet式24例)。Heller肌切开术加Dor胃底折叠术5例。结果:全组病人的平均手术时间为120(60～360)min,术中平均出血量15(10～100)ml,术后日平均引流量20(10～100)ml,平均住院7(5～12)d。其中前10例使用电刀者平均用时210(180～360)min,中转开腹1例;后40例使用超声刀者平均用时100(60～180)min。术中脾被膜划破出血2例,12例Nissen式胃底折叠术后有1例出现吞咽困难,1月后缓解。42例获随访的病人中40例不再需要服药。其中5例Heller肌切开术Dor胃底折叠术病人术后第2天即可顺畅进食,且无反流。结论:与传统的经胸或经腹手术相比,腹腔镜抗反流手术治疗胃食管反流病和Heller肌切开贲门失弛缓症的病人具有心肺干扰小、麻醉难度低、创伤小、痛苦轻、并发症少、住院时间短、康复快、疗效好等突出优点。经过不断改进手术设计和加强训练可使?     

改良三孔法腹腔镜下Heller肌切开联合胃底折叠治疗贲门失弛缓症

目的探讨三孔法腹腔镜下Heller肌切开联合胃底折叠治疗贲门失迟缓症的效果及优势。方法回顾性分析我院2006年7月～2011年10月完成的26例腹腔镜下Heller肌切开联合胃底折叠术的临床资料。手术采用三孔法,术中使用自制简易拉钩,行Heller肌切开联合Dor胃底折叠,观察术中及术后相关指标并随访。结果所有手术均获得成功,无中转开腹,手术时间65—260min,平均110．6rain。出血量25～100ml,平均53．2ml。术后住院时间3～7d,平均5．8d。1例术中食管黏膜破裂,修补后无食管漏。术后随访18～72个月,平均34．7月,无复发,饮食无明显不适。结论三孑L法腹腔镜下Heller肌切开联合胃底折叠治疗贲门失弛缓症具有手术部位显露效果好,创伤小,恢复快,治疗效果确切,安全,并发症少等优点,术后病人腹部美观,是治疗贲门失弛缓症的良好微创途径。     

胃食管结合部常见良性疾病的腹腔镜治疗

目的探讨腹腔镜手术治疗胃食管结合部常见良性疾病（胃食管反流病和贲门失弛缓症）的可行性和临床应用价值。方法2001年6月～2009年6月,对283例胃食管反流病（GERD组）实施腹腔镜胃底折叠术,其中Nissen胃底折叠术127例,Toupet胃底折叠术55例,Dor胃底折叠术101例;对33例贲门失弛缓症（贲门失弛缓症组）实施腹腔镜Heller肌切开联合Dor胃底折叠术。结果全组无中转开腹,手术时间60～125min,平均78min;术中出血量40～120ml,平均66ml;术后住院时间3～21d,平均4.2d。术后临床症状均得到缓解,无严重并发症及死亡病例。术后3个月复查胃镜、上消化道造影、食管测压和24hpH检测均恢复正常。GERD组272例随访3个月～8年,平均3.5年,对手术结果满意率95.6%（260/272）,21例有进固体食物时轻度哽噎感,6例反酸症状复发,使用抑酸药物可控制。贲门失弛缓症组33例随访3个月～4年,平均2.1年,均可正常进食,无吞咽困难或反酸表现。结论腹腔镜手术治疗胃食管结合部良性病变具有独特优势,充分体现微创手术创伤小、恢复快、安全可行、疗效可靠的优点。     

Achalasia and chest pain: Effect of laparoscopic heller myotomy

Some patients with achalasia complain of chest pain in addition to dysphagia and regurgitation. Chest pain is said to be most common in young patients who have been symptomatic for a short time, and who often have vigorous achalasia (distal esophageal amplitude ≥37 mm Hg). Although pneumatic dilatation is reported to improve chest pain in 20% of patients, the effect of laparoscopic Heller myotomy on chest pain is unknown. The aim of this study was to determine the following in achalasia: (1) the prevalence of chest pain; (2) the clinical and manometric profiles of patients with chest pain; and (3) the effect of laparoscopic Heller myotomy. Between 1990 and 2001, a total of 211 patients with achalasia were studied (upper gastrointestinal series, esophagoduodenoscopy, and manometry). A total of 117 patients (55%) had chest pain in addition to dysphagia and regurgitation; 63 (54%) of these 117 patients underwent laparoscopic Heller myotomy and Dor fundoplication. Median follow up was 24 months. Age (49 ± 16 years vs. 51 ± 14 years [mean ± SD]), duration of symptoms (71 ± 91 months vs. 67 ± 92 months [mean ± SD]), and presence of vigorous achalasia (50% vs. 47%) were similar in those with and without chest pain. Ten (16%) of the 63 patients with chest pain who underwent Heller myotomy had vigorous achalasia. Postoperatively chest pain resolved in 84% and improved in 11 % of patients. There was no difference in clinical outcome between patients with and without vigorous achalasia. These data demonstrate the following: (1) chest pain was present in 55% of patients with esophageal achalasia; (2) chest pain was not related to age, duration of symptoms, or manometric findings; and (3) laparoscopic Heller myotomy improved chest pain in 95% of patients, regardless of the manometric findings. Thus laparoscopic Heller myotomy was highly effective in treating achalasia with chest pain. Considered for the 2002 Grassi Prize, International Society of Digestive Surgery, Hong Kong, China, December 11, 2002.     

Robotic-assisted Heller myotomy for esophageal achalasia: feasibility, technique, and short-term outcomes

Laparoscopic Heller myotomy is the standard surgical treatment for esophageal achalasia. The incidence of esophageal perforation is about 5–10%. Robotic-assisted Heller myotomy (RAHM) offers results at least as good as those from laparoscopic procedures, additionally yielding fewer intraoperative complications. The aim of this study was to demonstrate the safety and feasibility of RAHM and its value in the treatment of esophageal achalasia. We analyzed demographics, preoperative symptoms, esophagograms, esophageal manometry, intraoperative and postoperative data of all the patients who underwent RAHM for achalasia at three institutions: 36 women and 37 men, mean age 45 ± 16 (13–87) years. Dysphagia was present in 100% of patients. Thirty-three patients (45%) had had previous endoscopic treatment: 23 patients had pneumatic dilation, four patients had Botox injections, and six patients had both. Surgical time averaged 119 min (range of 62–211); blood loss averaged 23 ml; no mucosal perforations were observed; length of hospitalization was 1.5 days; there were no deaths. At 12 months, 96% of patients had relief of their dysphagia. In conclusion, RAHM is safe and effective since there were no intraoperative esophageal perforations and relief of symptoms was achieved in 96% of the patients.     

经腹腔镜改良Heller手术加胃底折叠术治疗贲门失弛缓症

目的:探讨腹腔镜治疗贲门失弛缓症的方法及其优势。方法:经腹腔镜行食管贲门括约肌切开术(改良Heller手术)加胃底折叠术治疗贲门失弛缓症1例。结果:手术顺利,手术时间140m in,术中出血量30m l。患者术后第3天进软食无异常后出院。术后3个月食管下括约肌(LES)残留压、松弛率以及食管基础压均恢复正常,钡餐结果显示为正常食管影像,24h食管pH值测定正常,未见返流。随访6个月,症状无反复。结论:经腹腔镜改良Heller手术加胃底折叠术治疗贲门失弛缓症具有创伤小,术后康复快,疗效确切等优点。     

Laparoscopic Heller Myotomy for Achalasia Cardia—Initial Experience in a Teaching Institute

Laparoscopic Heller cardiomyotomy and Dor fundoplication is the surgical procedure of choice for esophageal achalasia. The aim of our study was to investigate the clinical outcome and safety of laparoscopic Heller–Dor procedure performed by using Hook electrocautery and as a teaching module for advanced laparoscopic surgery. Between January 2005 and December 2010, 25 consecutive patients with achalasia underwent laparoscopic Heller–Dor operation by a single surgeon. All the patients received upper gastrointestinal series (barium swallow), esophagogastroscopy, and esophageal manometry to exclude esophageal carcinoma and to confirm the diagnosis. All the patients were operated by laparoscopic modified Heller myotomy with Dor fundoplication by using hook electrocautery. Among 25 operated patients, 14 were male and 11 were female with a median age of 43 years (range 18–72 years). The mean operative time was 93.3 min (range 50–50 min), the mean operative blood loss was 90 ml (range 40–200 ml), the median time to oral feeding was 2 days (2–4 days), and the median hospital stay was 4 days (4–7 days). There was no conversion to open surgery. Intraoperative mucosal perforation was encountered in three patients and was repaired in all of them by laparoscopic suture. All the patients had an uneventful recovery without postoperative complication and had excellent clinical response (96 %) during follow-up. Laparoscopic Heller–Dor operation using hook electrocautery is safe, inexpensive, and effective treatment for achalasia which is useful for teaching and training surgical residents in advanced laparoscopic surgery.     

Prevalence of gastroesophageal reflux after laparoscopic Heller myotomy

Background: There is still some controversy over the need for antireflux procedures with Heller myotomy in the treatment of achalasia. This study was undertaken in an effort to clarify this question. Methods: To determine whether Heller myotomy alone would cause significant gastroesophageal reflux (GER), we studied 16 patients who had undergone laparoscopic Heller myotomy without concomitant antireflux procedures. Patients were asked to return for esophageal manometry and 24-h pH studies after giving informed consent for the Institutional Review Board (IRB)-approved study at a median follow-up time of 8.3 months (range, 3–51). Results are expressed as the mean ± SEM. Results: Fourteen of the 16 patients reported good to excellent relief of dysphagia after myotomy. They were subsequently studied with a 24-h pH probe and esophageal manometry. These 14 patients had a significant fall in lower esophageal sphincter (LES) pressure from 41.4 ± 4.2 mmHg to 14.2 ± 1.3 mmHg, after the myotomy (p < 0.01, Student's t-test). The two patients who reported more dysphagia postoperatively had LES pressures of 20 and 25 mmHg, respectively. Two of 14 patients had DeMeester scores of >22 (scores = 61.8, 29.4), while only one patient had a pathologic total time of reflux (percent time of reflux, 8%). The mean percent time of reflux in the other 13 patients was 1.9 ± 0.6% (range, 0.1–4%), and the mean DeMeester score was 11.7 ± 4.6 (range, 0.48–19.7). Conclusions: Laparoscopic Heller myotomy is effective for the relief of dysphagia in achalasia if the myotomy lowers the LES pressure to <17 mmHg. If performed without dissection of the entire esophagus, the laparoscopic Heller myotomy does not create significant GER in the postoperative period. Clearance of acid refluxate from the aperistaltic esophagus is an important component of the pathologic gastroesophageal reflux disease (GERD) seen after Heller myotomy for achalasia. Furthermore, GERD symptoms do not correlate with objective measurement of GE reflux in patients with achalasia. Objective measurement of GERD with 24 h pH probes may be indicated to identify those patients with pathologic acid reflux who need additional medical treatment. Received: 12 May 1998/Accepted: 15 December 1998     

The Outcome of Laparoscopic Heller Myotomy for Achalasia is Not Influenced by the Degree of Esophageal Dilatation

In the past, a Heller myotomy was considered to be ineffective in patients with achalasia and a markedly dilated or sigmoid-shaped esophagus. Esophagectomy was the standard treatment. The aims of this study were (a) to evaluate the results of laparoscopic Heller myotomy and Dor fundoplication in patients with achalasia and various degrees of esophageal dilatation; and (b) to assess the role of endoscopic dilatation in patients with postoperative dysphagia. One hundred and thirteen patients with esophageal achalasia were separated into four groups based on the maximal diameter of the esophageal lumen and the shape of the esophagus: group A, diameter <4.0 cm, 46 patients; group B, esophageal diameter 4.0–6.0 cm, 32 patients; group C, diameter >6.0 cm and straight axis, 23 patients; and group D, diameter >6.0 cm and sigmoid-shaped esophagus, 12 patients. All had a laparoscopic Heller myotomy and Dor fundoplication. The median length of follow-up was 45 months (range 7 months to 12.5 years). The postoperative recovery was similar among the four groups. Twenty-three patients (20%) had postoperative dilatations for dysphagia, and five patients (4%) required a second myotomy. Excellent or good results were obtained in 89% of group A and 91% of groups B, C, and D. None required an esophagectomy to maintain clinically adequate swallowing. These data show that (a) a laparoscopic Heller myotomy relieved dysphagia in most patients with achalasia, even when the esophagus was dilated; (b) about 20% of patients required additional treatment; (c) in the end, swallowing was good in 90%.     

Robotic heller myotomy and Dor fundoplication for achalasia in a woman with morbid obesity

Achalasia is a relatively rare condition with a prevalence estimated at less than 0.001?%. Laparoscopic or robotic Heller myotomy is an effective surgical treatment for achalasia. We present the first published case of a morbidly obese achalasia patient treated with robotic Heller myotomy and Dor fundoplication. The operative time was 175?min, with an estimated blood loss of 110?ml. The patient had a normal bowel transit on postoperative day 2, and he was discharged on postoperative day 4 on a liquid diet. A follow-up at 2?months showed significant resolved symptoms of achalasia.